These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7588780)

  • 1. Effects of ionic strength and pH on the binding of medium-chain fatty acids to human serum albumin.
    Pedersen AO; Mensberg KL; Kragh-Hansen U
    Eur J Biochem; 1995 Oct; 233(2):395-405. PubMed ID: 7588780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic parameters for binding of fatty acids to human serum albumin.
    Pedersen AO; Honoré B; Brodersen R
    Eur J Biochem; 1990 Jul; 190(3):497-502. PubMed ID: 2373077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristic acid binding to human serum albumin investigated by dialytic exchange rate.
    Pedersen AO; Brodersen R
    J Biol Chem; 1988 Jul; 263(21):10236-9. PubMed ID: 3392011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laurate binding to human serum albumin. Multiple binding equilibria investigated by a dialysis exchange method.
    Pedersen AO; Hust B; Andersen S; Nielsen F; Brodersen R
    Eur J Biochem; 1986 Feb; 154(3):545-52. PubMed ID: 3948866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid and drug binding to a low-affinity component of human serum albumin, purified by affinity chromatography.
    Vorum H; Pedersen AO; Honoré B
    Int J Pept Protein Res; 1992 Nov; 40(5):415-22. PubMed ID: 1483836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple binding of bilirubin to human serum albumin and cobinding with laurate.
    Sato H; Honoré B; Brodersen R
    Arch Biochem Biophys; 1988 Feb; 260(2):811-21. PubMed ID: 2829743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin.
    Kragh-Hansen U; Pedersen AO; Galliano M; Minchiotti L; Brennan SO; Tárnoky AL; Franco MH; Salzano FM
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):911-6. PubMed ID: 9003380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
    Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
    J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility of long-chain fatty acids in phosphate buffer at pH 7.4.
    Vorum H; Brodersen R; Kragh-Hansen U; Pedersen AO
    Biochim Biophys Acta; 1992 Jun; 1126(2):135-42. PubMed ID: 1627615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cobinding of bilirubin and laurate to human serum albumin: spectroscopic characterization of stoichiometric complexes.
    Honoré B; Sato H; Brodersen R
    Arch Biochem Biophys; 1988 Oct; 266(1):189-96. PubMed ID: 3178221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
    Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
    FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ionic strength on the binding of sodium aurothiosulphate to human serum albumin.
    Pedersen SM
    Biochem Pharmacol; 1985 Dec; 34(24):4319-23. PubMed ID: 3935116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylcholine-fatty acid membranes. I. Effects of protonation, salt concentration, temperature and chain-length on the colloidal and phase properties of mixed vesicles, bilayers and nonlamellar structures.
    Cevc G; Seddon JM; Hartung R; Eggert W
    Biochim Biophys Acta; 1988 May; 940(2):219-40. PubMed ID: 2835979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of histamine on dimedrol interaction with human serum albumin].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1985; 48(2):107-12. PubMed ID: 3996563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-of-dialysis technique: theoretical and practical aspects.
    Kragh-Hansen U; Dørge E; Pedersen AO
    Anal Biochem; 2005 May; 340(1):145-53. PubMed ID: 15802140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long chain fatty acid binding to human plasma albumin.
    Ashbrook JD; Spector AA; Santos EC; Fletcher JE
    J Biol Chem; 1975 Mar; 250(6):2333-8. PubMed ID: 234968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1).
    Rowlatt B; Yorke JA; Strong AJ; Whitehouse CJ; Bell SG; Wong LL
    Protein Cell; 2011 Aug; 2(8):656-71. PubMed ID: 21904981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and metabolism of fatty acids by dispersed adult rat heart myocytes. I. Kinetics of homologous fatty acids.
    DeGrella RF; Light RJ
    J Biol Chem; 1980 Oct; 255(20):9731-8. PubMed ID: 7430097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural heterogeneity of the binding sites of HSA for phenyl-groups and medium-chain fatty acids. Demonstration of equilibrium between different binding conformations.
    Lund M; Bjerrum OJ; Bjerrum MJ
    Eur J Biochem; 1999 Mar; 260(2):470-6. PubMed ID: 10095783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.